Zandra Hagman

964 total citations
11 papers, 801 citations indexed

About

Zandra Hagman is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zandra Hagman has authored 11 papers receiving a total of 801 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 6 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zandra Hagman's work include MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (6 papers) and Prostate Cancer Treatment and Research (5 papers). Zandra Hagman is often cited by papers focused on MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (6 papers) and Prostate Cancer Treatment and Research (5 papers). Zandra Hagman collaborates with scholars based in Sweden, United States and Finland. Zandra Hagman's co-authors include Anders Bjartell, Yvonne Ceder, Anders Edsjö, Olivia Larne, Hans Lilja, Benedikta S. Haflidadóttir, Anna Aakula, Olli Kallioniemi, Päivi Östling and Pekka Kohonen and has published in prestigious journals such as The EMBO Journal, Cancer Research and British Journal of Cancer.

In The Last Decade

Zandra Hagman

11 papers receiving 795 citations

Peers

Zandra Hagman

MB

CR

PRM

CB

ONCOL

Anna Aakula Finland

Huajie Bu Austria

Xu-Bao Shi United States

Maria A. Svensson Sweden

Daniela Schwarzenbacher Austria

Paul D. Cao United States

Maira M. Pires United States

Xiao-Song Wang United States

Maria V Yusenko Germany

Dorothee Pflueger United States

Anna Aakula Finland

Zandra Hagman

616 ×1.0

MB

462 ×0.8

CR

129 ×0.7

PRM

32 ×0.4

CB

71 ×1.6

ONCOL

Citations per year, relative to Zandra Hagman Zandra Hagman (= 1×) peers Anna Aakula

Countries citing papers authored by Zandra Hagman

Since Specialization

Citations

This map shows the geographic impact of Zandra Hagman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zandra Hagman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zandra Hagman more than expected).

Fields of papers citing papers by Zandra Hagman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zandra Hagman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zandra Hagman. The network helps show where Zandra Hagman may publish in the future.

Co-authorship network of co-authors of Zandra Hagman

This figure shows the co-authorship network connecting the top 25 collaborators of Zandra Hagman. A scholar is included among the top collaborators of Zandra Hagman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zandra Hagman. Zandra Hagman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Larne, Olivia, Zandra Hagman, Hans Lilja, et al.. (2015). miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis. Carcinogenesis. 36(8). 858–866. 57 indexed citations

2.

Hong, Xin, Thanh Nguyen, Qingfeng Chen, et al.. (2014). Opposing activities of the R as and H ippo pathways converge on regulation of YAP protein turnover. The EMBO Journal. 33(21). 2447–2457. 94 indexed citations

3.

Larne, Olivia, Päivi Östling, Benedikta S. Haflidadóttir, et al.. (2014). miR-183 in Prostate Cancer Cells Positively Regulates Synthesis and Serum Levels of Prostate-specific Antigen. European Urology. 68(4). 581–588. 34 indexed citations

4.

Hagman, Zandra, Benedikta S. Haflidadóttir, Marc Ansari, et al.. (2013). The tumour suppressor miR-34c targets MET in prostate cancer cells. British Journal of Cancer. 109(5). 1271–1278. 46 indexed citations

5.

Hagman, Zandra, Benedikta S. Haflidadóttir, Olivia Larne, et al.. (2013). miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients. British Journal of Cancer. 108(8). 1668–1676. 112 indexed citations

6.

Evans‐Axelsson, Susan, David Ulmert, Anders Örbom, et al.. (2012). Targeting Free Prostate-Specific Antigen for In Vivo Imaging of Prostate Cancer Using a Monoclonal Antibody Specific for Unique Epitopes Accessible on Free Prostate-Specific Antigen Alone. Cancer Biotherapy and Radiopharmaceuticals. 27(4). 243–251. 11 indexed citations

7.

Larne, Olivia, Elena S. Martens‐Uzunova, Zandra Hagman, et al.. (2012). miQ—A novel microRNA based diagnostic and prognostic tool for prostate cancer. International Journal of Cancer. 132(12). 2867–2875. 72 indexed citations

8.

Östling, Päivi, Suvi‐Katri Leivonen, Anna Aakula, et al.. (2011). Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells. Cancer Research. 71(5). 1956–1967. 227 indexed citations

9.

Östling, Päivi, Suvi‐Katri Leivonen, Anna Aakula, et al.. (2011). Abstract 3977: Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells. Cancer Research. 71(8_Supplement). 3977–3977. 3 indexed citations

10.

Hagman, Zandra, Olivia Larne, Anders Edsjö, et al.. (2010). miR‐34c is downregulated in prostate cancer and exerts tumor suppressive functions. International Journal of Cancer. 127(12). 2768–2776. 137 indexed citations

11.

Östling, Päivi, Suvi‐Katri Leivonen, Anna Aakula, et al.. (2010). Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact